Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury

NCT00004759 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

497

Enrollment

NIH

Sponsor class

Conditions

Spinal Cord Injury

Interventions

DRUG: methylprednisolone
DRUG: tirilazad

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborators

[object Object]